News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Freed Martin I
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/08/2023 |
4
| Freed Martin I (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.37, valued at
$61.5k
|
|
| 12/15/2022 |
4
| Freed Martin I (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 9,650 options to buy
@ $6.47, valued at
$62.4k
|
|
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/29/2021 |
4
| Freed Martin I (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Unknown transaction of 3,333 shares
@ $38.25, valued at
$127.5k
Disposed/sold 3,333 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $3.26, valued at
$81.5k
Disposed/sold 25,000 options to buy
@ $3.42, valued at
$85.5k
Disposed/sold 25,000 options to buy
@ $13.08, valued at
$327k
Disposed/sold 25,000 options to buy
@ $15.44, valued at
$386k
Disposed/sold 15,000 options to buy
@ $21.61, valued at
$324.2k
Disposed/sold 15,000 options to buy
@ $30.47, valued at
$457.1k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| Freed Martin I (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 3,333 restricted stock units
@ $0
Granted 15,000 options to buy
@ $21.61, valued at
$324.2k
|
|
| 07/29/2019 |
4
| Freed Martin I (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 53,763 shares
@ $4.65, valued at
$250k
|
|
| 06/21/2019 |
4
| Freed Martin I (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 25,000 options to buy
@ $15.44, valued at
$386k
|
|
| 06/14/2019 |
4
| Freed Martin I (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 10,000 options to buy
@ $5.26, valued at
$52.6k
|
|
| 12/17/2018 |
4
| Freed Martin I (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 16,331 options to buy
@ $23.58, valued at
$385.1k
|
|
| 07/26/2018 |
4
| Freed Martin I (Director) has filed a Form 4 on Solid Biosciences Inc.|
Txns:
| Granted 3,669 options to buy
@ $37.89, valued at
$139k
|
|
| 06/27/2018 |
3
| Freed Martin I (Director) has filed a Form 3 on Solid Biosciences Inc. |
| 06/25/2018 |
4
| Freed Martin I (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 25,000 options to buy
@ $13.08, valued at
$327k
|
|
| 07/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2016 |
4
| Freed Martin I (Director) has filed a Form 4 on Dicerna Pharmaceuticals Inc|
Txns:
| Granted 25,000 options to buy
@ $3.26, valued at
$81.5k
|
|
| 06/15/2016 |
3
| Freed Martin I (Director) has filed a Form 3 on Dicerna Pharmaceuticals Inc |
|
|